PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression-Reference-Cited by-同舟云学术

PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression

Published:2017-06-21 Issue:6 Volume:18 Page:1331
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Šmahel Michal^ORCID

Funder

Czech Science Foundation

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/6/1331/pdf

Reference93 articles.

1. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J.,1992

2. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

3. PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo

4. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

5. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manganese (III) phthalocyanine complex nanoassembly: Oxygen-Independent generation of superoxide radicals and singlet oxygen for ultrasound-augmented chemodynamic therapy;Chemical Engineering Journal;2024-09

2. Study on the inflammatory microenvironment of Epstein‒Barr virus-infected Hodgkin's lymphoma;2024-06-18

3. Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer;Cancer Letters;2024-06

4. Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell–Mediated Cancer Stem Cell Aggression;Molecular Cancer Research;2024-05-14

5. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer;Cancer Letters;2024-04